Strategic Results JV Receives 8(a) Stars III Award

 Strategic Results (SR) announced today that its Joint Venture, Z4E Strategic Results Alliance LLC, received the prestigious Best-in-Class GSA 8(a) STARS III award. This multiple-award indefinite delivery-quantity (MA-ID/IQ) contract is designed to provide federal agencies with innovative information technology (IT) services-based solutions from award-winning small businesses.

Through this award, Z4E Strategic Results Alliance will be able to provide customized IT solutions to meet federal agencies’ individual mission needs, such as data management, IT operations and maintenance, IT security, and software development and systems design. Due to SR’s strong past performance, the JV was selected for the emerging technology-focused scope sub-area, which is intended to accelerate transformation. Services typical in this sub-area include artificial intelligence, autonomic computing, blockchain/distributed ledger, quantum computing, robotic process automation, technological convergence, and virtual reality.

“This contract offers an excellent resource for federal agencies, and we are pleased that this award will allow us to build on our previous successes providing innovative IT solutions in support of our clients’ missions,” said Anne Dunne, CEO of Strategic Results.

About JV: Strategic Results and Z4 Enterprises (Z4E), a service-disabled veteran-owned small business, formed a Joint Venture in 2017. Strategic Results is a technology and communications management company based in the Washington, D.C., region with 25 years of experience achieving extraordinary results to federal agencies and commercial clients. Z4E specializes in providing engineering and professional services in support of acquisition professionals. The partnership allows SR to leverage more than two decades of experience navigating the federal space to mentor and provide opportunities to a veteran-owned business in the federal marketplace. Since its inception, the Z4E Strategic Results Alliance LLC has won multiple awards, including those with the Department of Transportation’s Transportation Safety Institute and the Department of Defense, Defense Media Activity Acquisitions and Project Management offices.

For more information, call 240.477.4097 or visit

Strategic Results

Jill Gross




  • Awards

Strategic Executive Growth Leader Jeff Muench Joins AlgoFace

 AlgoFace Inc, an ethical face AI enablement platform, is pleased to announce that executive leader & growth expert Jeff Muench is joining the team as a Strategic Advisor. As a strategic expert who brings teams together to accomplish the unexpected, Jeff will assist Algoface’s corporate development, mergers and acquisitions, and strategic partnerships.

“I’m very excited to join AlgoFace because they’re creatively leveraging technology to remove consumer friction, thus creating a future I’m enthusiastic to help build. AlgoFace’s accomplished team of interesting people with diverse skills lends a unique perspective. It’s amazing and humbling to be part of this fantastic team,” Jeff says.

“Jeff’s experience helping to craft and operate Walmart’s Mergers and Acquisitions integration practice along with his deep understanding of retail marketing and transformation strategies is a perfect fit,” says Andrew Bart, CEO & Cofounder of AlgoFace. “Jeff’s knowledge of what types of innovation our enterprise customers are seeking, his pedigree, and his relationships will open doors for us.”

About Jeff Muench

Jeff brings over 20 years of strategy, general management, marketing, branding, and mergers and acquisitions integration experience. Jeff is recognized for overcoming challenges with inventive, entrepreneurial, and customer-centric efforts that capture significant market share and lead organizations to unimagined places, all while improving user experience. He successfully identifies unmet customer needs and pain points, engineers solutions, enhances revenues, manages costs intelligently, and develops high-achieving collaborative teams with an entrepreneurial “team mindset” across multiple industries.

After serving as a Peace Corps Volunteer in Central Africa and as a US Senate aide, Jeff embarked on his business career beginning with brand management at J&J, PepsiCo, and ConAgra. Most recently Jeff spent nine years at Walmart in a variety of leadership roles including transformation strategy and execution for Supercenter Reinvention, marketing for the $78B consumables and health & wellness businesses, creating the Effie-awarded and most impactful advertising campaign in Walmart history, and building the M&A integration process. Two teams he led were awarded Walmart team of the year. Jeff graduated with an MBA from the University of North Carolina at Chapel Hill and a bachelors in political science from Sewanee, the University of the South.

About AlgoFace

AlgoFace builds AR and AI technology that knows what’s unique in every person. Through precise tracking of 209 facial landmarks, AlgoFace technology enables a deeper understanding of the human form, to detect and recognize people more accurately, more easily and more clearly. AlgoFace works with leading brands, agencies and OEM partners to power face AI applications. Headquartered in Carefree, Arizona, they are a diverse team of passionate innovators with deep rooted knowledge in computer vision, augmented reality and applied artificial intelligence applications. For more information, please visit


Jeffrey Freedman




  • Personnel Announcements

ADAX Announces New Strategic Partnership with the Co-Founder of, Mate Tokay

Nicosia, Cyprus, 26 June 2021, ZEXPRWIRE, ADAX, the Cardano-based state-of-the-art decentralized exchange protocol, has announced a new strategic partnership with Mate Tokay, co-founder of The legendary crypto investor has put his bet in ADAX by investing in the project, consequently joining the strategic advisors’ team.

ADAX boasts a team with a track record of success in various crypto ventures. By joining the team as a strategic advisor, Mate is bringing in a wealth of experience, know-how, and best industry practices to see the team amplifies the benefits to users of the platform within the Cardano network. The partnership also affirms ADAX’s overall potential as a project that is built for the future and can only be seen to grow going forward and add value to investors.

About Mate Tokay

Mate is a big Cardano supporter and enthusiast, and his decision to be part of ADAX, a project built on the Cardano network is a big plus for the team that has put their faith in Cardano as the blockchain of the future. He joins the ADAX team to push his vision of enabling the world to access cryptocurrencies, including more financial services.

A renowned entrepreneur whose journey to entrepreneurship began way back in 2012 after graduating from the International Business School in Budapest, Mate was part of the team that launched Superior14, a food supplement company. Later in the same year, he would hear about Bitcoin.

Mate became involved in Bitcoin in late 2012 and started mining in mid-2013 using custom-built ASIC miners. Seeing an opportunity to share developments in the ecosystem, he founded the Bitcoin news and review site, later going on to sell the site and Co-founded with Roger Ver. His ultimate goal and passion are to make cryptocurrencies as widely used as possible and loves traveling to conferences to meet new people involved in the space. An all-around sports enthusiast, Mate is a former wakeboard world champion and currently enjoys CrossFit and Tennis. As far as Cardano goes Mate has been a long-time believer and got his first ADA bag below 0.3 cents. Mate’s main goal and passion is to make cryptocurrencies as popular as possible, which is in line with both ADAX and Cardano’s objectives.

About ADAX

ADAX is an automated liquidity protocol that facilitates trades within the Cardano ecosystem completely decentralized and non-custodial. The platform is built to lower the cost of transactions and shorten the network transaction, hence designed without order books. The elimination of intermediaries, complexities, and cumbersome processes from the equation will provide users with unhindered freedom to trade without censorship or loss of control of their assets. The decentralization is meant to liberalize financial transactions, allow more users to access cryptocurrencies, and take control of their cryptocurrency data/assets without involving a third party. ADAX aims to offer more transparent, secure, and faster transactions.

The partnership adds to an already growing list of strategic partnerships that are already taking shape. Check out Adax signs partnership with Charli3.

Also, take note of the following important events:

·  Adax IEO ends on June 25th

·  Adax Cardano Native Token listing is on June 26th

·  Adax Staking will start on June 29th

NEC and MTI enter strategic partnership to accelerate Open RAN deployments globally

NEC Corporation (NEC; TSE: 6701), a leader in the integration of IT and network technologies, and Microelectronics Technology Inc. (MTI; TAIEX: 2314), a leading network RF solutions provider, today announced a collaboration to enhance the Open RAN ecosystem with a variety of radio options to cater to global 4G and 5G markets.

This strategic partnership is intended to provide a broader Open RAN product offering for Communication Service Providers (CSPs) and enable various use cases ranging from rural to urban areas, with network configurations and performance profiles, such as non and massive MIMO.

Under this agreement, NEC and MTI will jointly bring to market radio units to meet the increasing need for more Open RAN radios. NEC and MTI will continue to meet the high-quality standards required for Tier-1 operators deploying Open RAN networks across the globe.

In response to the market demands for supply chain diversification ensuring carrier-grade performance, reliability and availability, NEC has implemented a variety of different options to increase its Open RAN and disaggregated product portfolio. This strategic partnership extends NEC’s Open RAN product lineup, addressing a vast market opportunity.

“NEC is an industry leader in open and disaggregated networks, demonstrating its capabilities in integrating end-to-end Open RAN solutions,” said Allen Yen, Chairman and CEO of MTI. “MTI is excited to be one of NEC’s strategic partners to jointly address the need for open, high performance, high quality 5G radio products.”

“An open, disaggregated 5G network ecosystem promises to drive transformation throughout the industry,” said Shigeru Okuya, Senior Vice President, NEC Corporation. “With this firm and strategic partnership with MTI, NEC reinforces its commitment to accelerate commercial Open RAN deployments and to deliver more value to its customers.”

About MTI

Microelectronics Technology Inc. (MTI) is a high-technology company that has specialized in wireless communication product development, manufacturing, and global sales for more than 35 years. Based on core competency in RF/ Microwave, MTI has established a leading position in the fields of Remote Radio Heads, Microwave Radios, Satellite Transceivers and ODUs, Broadband Wireless access products, and Radio Frequency Identification (RFID) readers and modules. With this excellent record of accomplishment, MTI has established valued, long-term partnerships with world-leading partners.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at

Topic: Press release summary

Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the “CMS”, SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration, including but not limited to setting up an aesthetic medical marketing centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong , and exploring to set up an aesthetic medical training and education platform for registered practitioners, and further exploring the formation of a nationwide aesthetic medical doctor partnership business platform.

The Group is the largest non-hospital medical service provider in Hong Kong based in the Greater Bay Area, providing medical, aesthetic medical and healthcare services. The CMS Group is an innovation-driven specialty pharma with a focus on sales and marketing in China, with more than two decades proven record of experience in successful drug promotion in multi departments. Of vertical development in the specialist field, the CMS Group is consistently expanding its horizontal boundary at the same and deploy product matrix in leading skin management and medical aesthetic technology. According to the memorandum, the Group and CMS will set up and operate an aesthetic medical marketing centre in Hong Kong as starting point for distribution, sales and marketing of aesthetics medication and related products in Hong Kong, set up an aesthetic medical training and education platform for registered practitioners to provide aesthetic medical services, and further explore the formation of a nationwide aesthetic medical doctor partnership business platform, in order to strategically link up upstream and downstream of aesthetic medical industry to maximize the industry synergy, promote the compliance of aesthetic medical products, foster the commercialisation of aesthetic medical professionals, and standardize aesthetic medical services.

Under the strategic collaboration, CMS intends to inject the medication resources on its research and development platform and the distribution rights of aesthetic medication or related products in Hong Kong; EC Healthcare intends to inject its digital marketing system, team of registered practitioners, resources of key opinion leaders and celebrity spokespersons and its branding influence as a market leader in the industry. Besides, by leveraging CMS’s vast network of medical practitioners in the China and EC Healthcare’s aesthetic medical education expertise, the parties will establish as an education and training centre for cultivating and certifying a new generation of aesthetic medical talents, and actively explore the formation of a nationwide aesthetic medical doctor partnership business platform.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, “The Group is honored to establish a long-term strategic partnership with CMS. Both parties will fully exploit their respective advantages to realize a strong alliance. In the past few years, EC Healthcare’s outstanding performance continued to prove the Group’s brand power and operational capabilities in the Greater Bay Area and across the country. Through the collaboration, we hope to facilitate the Group’s precise layout in mainland market and scale the aesthetic medical business to a new height through replicating the successful operation system. In light of the strong growth potential of China’s aesthetic medical services market, as well as the shortage of compliant aesthetics medication and talents, the Group believes that the collaboration can promote valuable synergies between the upstream and downstream of the industry, thereby leading the development of pharmaceuticals and medical talents in order to reform the industry and resolve the pain points in response to the strong domestic demand for high-quality compliant aesthetic medical services.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group’s high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories and a professional hair care center HAIR FOREST.

*According to an independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020

About China Medical System
China Medical System Holdings Limited is an innovation-driven specialty pharma with a focus on sales and marketing in China, dedicated to offering competitive products and services to meet China’s unmet needs for health and beauty.

CMS focuses on innovative products that are global first-in-class, or with the best efficacy, safety or cost-effectiveness in the class due to their innovative formulations or drug delivery systems, and has built an innovative product pipeline with relatively high innovation level, good market potential and competitive differentiation advantages. Meanwhile, CMS has proven and successful experience in drug commercialization and strong capability in professional academic promotion, having created a leading market position for many existing drugs. Jointly driven by the strong product competence, the powerful academic promotion capability, and the refined internal management system, CMS has become one of the Chinese pharmaceutical companies with the highest operating efficiency.

Capitalizing on its own advantages, CMS constantly expands the business boundaries and rapidly promotes the development of new businesses, which consist of the dermatology and medical aesthetic business (CMS Aesthetics) and the healthcare business (CMS Health), while making in-depth development in multiple fields of expertise. CMS Aesthetics specializes in the development of dermatological drugs and medical aesthetic solutions, dedicated to becoming the largest and most professional company in the field of dermatology, medical aesthetics and health management in China. CMS Health stringently selects functional quality healthcare products with unique ingredients globally according to medical concept and high standards, and forms one-stop cross-border e-commerce platforms, to help Chinese consumers improve their sub-health status.

For further information, please contact:
iPR Ogilvy Limited
Callis Lau / Lorraine Luk / Shana Li / Ada Chew
Tel: (852) 2136 6952 / 2169 0467 / 3920 7649 / 3920 7650
Fax: (852) 3170 6606

Topic: Press release summary